Chenguang Biotech Group Total Liabilities
Chenguang Biotech Group total liabilities. Based on the latest financial reports, Chenguang Biotech Group (300138) has total liabilities worth CN¥6.16 Billion CNY (≈ $901.48 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are Chenguang Biotech Group's assets to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Chenguang Biotech Group (2007–2025)
Total liabilities of Chenguang Biotech Group from 2007 to 2025. This chart illustrates how Chenguang Biotech Group's total liabilities have evolved over time, based on quarterly financial data. Explore Chenguang Biotech Group long-term investment allocation to see how much of total assets are deployed in long-term investments.
Chenguang Biotech Group Competitors by Total Liabilities
The table below lists competitors of Chenguang Biotech Group ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Fuxin Dare Automotive Parts Co Ltd
SHE:300473
|
China | CN¥2.80 Billion |
|
Arcos Dorados Holdings Inc
NYSE:ARCO
|
USA | $3.06 Billion |
|
Net263 Ltd
SHE:002467
|
China | CN¥389.16 Million |
|
Suzhou New District Hi Tech Industrial Co Ltd
SHG:600736
|
China | CN¥59.74 Billion |
|
Gansu Yasheng Industrial Group Co Ltd
SHG:600108
|
China | CN¥5.69 Billion |
|
Time Technoplast Limited
NSE:TIMETECHNO
|
India | Rs-41.66 Billion |
|
GuoChuang Software Co Ltd
SHE:300520
|
China | CN¥1.89 Billion |
|
CeriBell, Inc
NASDAQ:CBLL
|
USA | $38.03 Million |
Liability Composition Analysis (2007–2025)
This chart breaks down Chenguang Biotech Group's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Chenguang Biotech Group balance sheet assets.
Liquidity & Leverage Metrics
Chenguang Biotech Group Total Liabilities Ratios Explained
Chenguang Biotech Group total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.28 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.81 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.64 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Chenguang Biotech Group's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Chenguang Biotech Group (2007–2025)
The table below shows the annual total liabilities of Chenguang Biotech Group from 2007 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥6.07 Billion ≈ $887.57 Million |
+3.37% |
| 2024-12-31 | CN¥5.87 Billion ≈ $858.65 Million |
+17.18% |
| 2023-12-31 | CN¥5.01 Billion ≈ $732.73 Million |
+34.98% |
| 2022-12-31 | CN¥3.71 Billion ≈ $542.84 Million |
+16.96% |
| 2021-12-31 | CN¥3.17 Billion ≈ $464.13 Million |
+22.23% |
| 2020-12-31 | CN¥2.59 Billion ≈ $379.72 Million |
-6.18% |
| 2019-12-31 | CN¥2.77 Billion ≈ $404.75 Million |
+71.07% |
| 2018-12-31 | CN¥1.62 Billion ≈ $236.61 Million |
+29.47% |
| 2017-12-31 | CN¥1.25 Billion ≈ $182.75 Million |
+29.09% |
| 2016-12-31 | CN¥967.46 Million ≈ $141.57 Million |
+71.50% |
| 2015-12-31 | CN¥564.12 Million ≈ $82.55 Million |
+12.89% |
| 2014-12-31 | CN¥499.69 Million ≈ $73.12 Million |
-22.08% |
| 2013-12-31 | CN¥641.26 Million ≈ $93.84 Million |
+43.23% |
| 2012-12-31 | CN¥447.73 Million ≈ $65.52 Million |
+204.24% |
| 2011-12-31 | CN¥147.16 Million ≈ $21.53 Million |
-31.84% |
| 2010-12-31 | CN¥215.92 Million ≈ $31.60 Million |
+12.36% |
| 2009-12-31 | CN¥192.17 Million ≈ $28.12 Million |
-19.02% |
| 2008-12-31 | CN¥237.31 Million ≈ $34.73 Million |
+177.57% |
| 2007-12-31 | CN¥85.49 Million ≈ $12.51 Million |
-- |
About Chenguang Biotech Group
ChenGuang Biotech Group Co., Ltd. develops and produces natural colors, spice extracts and essential oils, nutritional and pharmaceutical extracts, and oils and protein. The company offers natural colors, including paprika oleoresin, marigold oleoresin, and turmeric; spice extracts and essential oils, such as capsicum oleoresin, sichuan pepper oil, pepper oleoresin, ginger extract, and cumin oleo… Read more